Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers. | Cell Death Discov | 2025 | 40858533 | PubTator, text mining | PubMed |
| LENG8 mediates RNA nuclear retention and degradation in eukaryotes. | bioRxiv | 2025 | 40832163 | PubTator, text mining | PubMed |
| A multi-omic integrative approach combining m6A-epitranscriptomic, transcriptomic, and splicing alternative events reveals potential candidates for colorectal cancer diagnosis. | Genes Dis | 2025 | 40808875 | PubTator, text mining | PubMed |
| Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy. | J Transl Med | 2025 | 40804394 | PubTator, text mining | PubMed |
| Hyperactivation of the m6A demethylase FTO to down-regulate SLC7A11/xCT-mediated redox homeostasis and epigenetic remodeling in facial infiltrating lipomatosis. | Free Radic Biol Med | 2025 | 40769313 | PubTator, text mining | PubMed |
| FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization. | Cell Biol Toxicol | 2025 | 40760370 | PubTator, text mining | PubMed |
| Aberrant pace of cortical neuron development in brain organoids from patients with 22q11.2 deletion syndrome-associated schizophrenia. | Nat Commun | 2025 | 40750773 | PubTator, text mining | PubMed |
| M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges. | Front Oncol | 2025 | 40740874 | PubTator, text mining | PubMed |
| Multi-proteomic profiling of the varicella-zoster virus-host interface reveals host susceptibilities to severe infection. | Nat Microbiol | 2025 | 40739040 | PubTator, text mining | PubMed |
| Potential regulatory role of the m 6A-lncRNA axis in breast cancer: molecular mechanisms and therapeutic implications. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40726278 | PubTator, text mining | PubMed |
| M6A-dependent RNA condensation underlies FUS autoregulation and can be harnessed for ALS therapy development. | Sci Adv | 2025 | 40700505 | PubTator, text mining | PubMed |
| Non-invasive colorectal cancer biomarkers: HAND2 and GPM6A methylation in circulating tumour DNA. | Cancer Cell Int | 2025 | 40682031 | PubTator, text mining | PubMed |
| M6A-mediated uc003pes.1 stability regulates proliferation and migration of human coronary artery smooth muscle cells via scaffolding STAT1 and USP10. | Biochim Biophys Acta Mol Cell Res | 2025 | 40669772 | PubTator, text mining | PubMed |
| Potential role of N6-methyladenosine modification in circular RNA biogenesis and function in the inflammatory responses. | Front Mol Med | 2025 | 40642107 | PubTator, text mining | PubMed |
| M6A RNA epitranscriptome dynamics linked to major depressive disorder and suicide risk. | Neuropsychopharmacology | 2025 | 40640508 | PubTator, text mining | PubMed |
| Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma. | BMC Cancer | 2025 | 40597017 | PubTator, text mining | PubMed |
| Identification of exosome-related genes in NSCLC via integrated bioinformatics and machine learning analysis. | Sci Rep | 2025 | 40595797 | PubTator, text mining | PubMed |
| m6A mRNA demethylase FTO promotes chondrogenic differentiation of human bone marrow mesenchymal stem cells by targeting SMAD3. | Stem Cells | 2025 | 40570063 | PubTator, text mining | PubMed |
| A multi-type programmed cell death gene signature predicts survival and reveals therapeutic targets in osteosarcoma. | Discov Oncol | 2025 | 40522389 | PubTator, text mining | PubMed |
| Principles and functional consequences of plasmid chromatinization in mammalian cells. | bioRxiv | 2025 | 40501650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=4